Anthropometric Phenotype of Patients with PMM2-CDG

Patryk Lipiński1, Agnieszka Różdżyńska-Świątkowska2, Anna Bogdańska3

  • 1Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.

Insights

Children with PMM2-CDG often experience growth failure. Patients with the R141H variant showed more severe growth and head circumference deficits, highlighting genotype-phenotype correlations.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Genetics
  • Human Growth and Development

Background:

  • Congenital disorder of glycosylation type II (PMM2-CDG) is frequently associated with growth failure in pediatric populations.
  • Understanding the detailed growth patterns and their genetic underpinnings is crucial for patient management.

Purpose of the Study:

  • To characterize the longitudinal anthropometric phenotype in children with PMM2-CDG.
  • To investigate potential correlations between specific PMM2 genotypes and observed anthropometric outcomes.

Main Methods:

  • Retrospective review of medical records for PMM2-CDG patients.
  • Analysis of anthropometric data including head circumference, body length/height, body weight, and BMI.
  • Correlation of phenotypic data with identified PMM2 gene variants.

Main Results:

  • A general trend of negative growth evolution was observed across the patient cohort.
  • Patients heterozygous for the R141H PMM2 variant exhibited significantly slower growth rates compared to other patients.
  • Body weight demonstrated a positive correlation with body height, and head circumference growth showed a negative trend.

Conclusions:

  • Long-term observational studies are vital for comprehensively defining the anthropometric phenotype of PMM2-CDG.
  • Growth failure, particularly in body size and head circumference, is more pronounced in PMM2-CDG patients carrying the R141H heterozygous variant.
Abstract